| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Fluorescence | 44 | 2023 | 208 | 8.370 |
Why?
|
| Skin Neoplasms | 29 | 2023 | 159 | 4.690 |
Why?
|
| Prostatic Neoplasms | 17 | 2023 | 935 | 3.550 |
Why?
|
| Breast Neoplasms | 22 | 2023 | 1502 | 3.550 |
Why?
|
| Spectrum Analysis, Raman | 9 | 2021 | 88 | 3.510 |
Why?
|
| Tryptophan | 15 | 2019 | 73 | 3.460 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2014 | 61 | 2.430 |
Why?
|
| NAD | 13 | 2017 | 50 | 2.420 |
Why?
|
| Dermoscopy | 22 | 2020 | 22 | 2.360 |
Why?
|
| Diagnostic Imaging | 9 | 2013 | 53 | 2.280 |
Why?
|
| Infrared Rays | 6 | 2017 | 18 | 2.070 |
Why?
|
| Melanoma | 14 | 2023 | 96 | 2.070 |
Why?
|
| Collagen | 14 | 2024 | 172 | 2.020 |
Why?
|
| Spectroscopy, Near-Infrared | 8 | 2017 | 30 | 1.990 |
Why?
|
| Brain | 9 | 2023 | 1346 | 1.930 |
Why?
|
| Prostate | 6 | 2023 | 154 | 1.910 |
Why?
|
| Tomography, Optical | 6 | 2012 | 6 | 1.870 |
Why?
|
| Laser Therapy | 6 | 2015 | 30 | 1.850 |
Why?
|
| Scattering, Radiation | 12 | 2017 | 47 | 1.720 |
Why?
|
| Humans | 138 | 2024 | 37093 | 1.700 |
Why?
|
| Algorithms | 12 | 2023 | 465 | 1.690 |
Why?
|
| Lasers | 17 | 2024 | 65 | 1.590 |
Why?
|
| Breast | 10 | 2019 | 135 | 1.580 |
Why?
|
| Refractometry | 3 | 2023 | 14 | 1.430 |
Why?
|
| Optics and Photonics | 7 | 2017 | 28 | 1.350 |
Why?
|
| Skin | 13 | 2023 | 174 | 1.310 |
Why?
|
| Diagnosis, Computer-Assisted | 4 | 2016 | 24 | 1.290 |
Why?
|
| Sensitivity and Specificity | 17 | 2023 | 562 | 1.250 |
Why?
|
| Photons | 5 | 2016 | 29 | 1.200 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2014 | 173 | 1.190 |
Why?
|
| Carcinoma, Basal Cell | 4 | 2021 | 20 | 1.190 |
Why?
|
| Fluorescence Polarization | 4 | 2013 | 30 | 1.180 |
Why?
|
| Nephelometry and Turbidimetry | 5 | 2012 | 10 | 1.140 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 803 | 1.080 |
Why?
|
| Pattern Recognition, Automated | 4 | 2014 | 31 | 1.060 |
Why?
|
| Neoplasms | 8 | 2017 | 1103 | 1.050 |
Why?
|
| Carotenoids | 6 | 2020 | 70 | 1.040 |
Why?
|
| Animals | 42 | 2024 | 15081 | 1.020 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 111 | 1.020 |
Why?
|
| Molecular Imaging | 2 | 2016 | 30 | 1.020 |
Why?
|
| Psoriasis | 6 | 2022 | 17 | 0.990 |
Why?
|
| Welding | 1 | 2024 | 1 | 0.960 |
Why?
|
| Microscopy, Confocal | 5 | 2020 | 218 | 0.950 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2012 | 84 | 0.940 |
Why?
|
| Principal Component Analysis | 8 | 2021 | 89 | 0.910 |
Why?
|
| Meningeal Neoplasms | 2 | 2021 | 5 | 0.910 |
Why?
|
| Meningioma | 2 | 2021 | 7 | 0.910 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2014 | 39 | 0.910 |
Why?
|
| Microscopy, Fluorescence | 4 | 2017 | 252 | 0.880 |
Why?
|
| Female | 51 | 2023 | 20969 | 0.880 |
Why?
|
| Photosynthesis | 3 | 2021 | 29 | 0.840 |
Why?
|
| Models, Theoretical | 4 | 2020 | 217 | 0.830 |
Why?
|
| Wound Healing | 2 | 2015 | 70 | 0.820 |
Why?
|
| Swine | 10 | 2024 | 184 | 0.820 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2020 | 178 | 0.820 |
Why?
|
| Aorta | 4 | 2016 | 167 | 0.820 |
Why?
|
| Flavin-Adenine Dinucleotide | 3 | 2017 | 7 | 0.810 |
Why?
|
| Models, Chemical | 4 | 2013 | 207 | 0.790 |
Why?
|
| Male | 45 | 2023 | 20025 | 0.780 |
Why?
|
| Biopsy | 5 | 2023 | 164 | 0.770 |
Why?
|
| Bacillus subtilis | 3 | 2006 | 16 | 0.760 |
Why?
|
| Image Enhancement | 5 | 2012 | 40 | 0.750 |
Why?
|
| Contrast Media | 3 | 2011 | 92 | 0.740 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 935 | 0.720 |
Why?
|
| Acetone | 1 | 2020 | 7 | 0.720 |
Why?
|
| Light | 6 | 2024 | 187 | 0.710 |
Why?
|
| Methanol | 1 | 2020 | 18 | 0.710 |
Why?
|
| Chlorophyll | 4 | 2021 | 22 | 0.690 |
Why?
|
| Nanostructures | 1 | 2021 | 134 | 0.670 |
Why?
|
| Glioma | 1 | 2019 | 79 | 0.660 |
Why?
|
| Fibroadenoma | 3 | 2011 | 4 | 0.640 |
Why?
|
| Colloids | 3 | 2014 | 17 | 0.640 |
Why?
|
| Lymph Nodes | 2 | 2017 | 67 | 0.630 |
Why?
|
| Equipment Design | 6 | 2020 | 124 | 0.610 |
Why?
|
| Hot Temperature | 5 | 2011 | 128 | 0.610 |
Why?
|
| Dermatitis, Atopic | 3 | 2021 | 12 | 0.590 |
Why?
|
| Elastin | 5 | 2013 | 40 | 0.580 |
Why?
|
| Alopecia Areata | 3 | 2021 | 3 | 0.580 |
Why?
|
| Skin Physiological Phenomena | 2 | 2009 | 11 | 0.580 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 61 | 0.560 |
Why?
|
| Microscopy, Polarization | 3 | 2005 | 4 | 0.560 |
Why?
|
| Spores, Bacterial | 3 | 2006 | 10 | 0.560 |
Why?
|
| Dermatologic Agents | 3 | 2021 | 9 | 0.550 |
Why?
|
| Fluorescence | 8 | 2013 | 121 | 0.550 |
Why?
|
| Indocyanine Green | 2 | 2013 | 3 | 0.530 |
Why?
|
| Tomography | 3 | 2016 | 9 | 0.520 |
Why?
|
| Tinea | 3 | 2020 | 7 | 0.520 |
Why?
|
| Chickens | 5 | 2017 | 133 | 0.500 |
Why?
|
| Picolinic Acids | 2 | 2006 | 12 | 0.500 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 14 | 0.500 |
Why?
|
| Lasers, Solid-State | 2 | 2011 | 13 | 0.500 |
Why?
|
| Microvessels | 1 | 2014 | 28 | 0.490 |
Why?
|
| Spinacia oleracea | 1 | 2014 | 8 | 0.490 |
Why?
|
| Optical Phenomena | 4 | 2019 | 20 | 0.480 |
Why?
|
| Fluorescent Dyes | 6 | 2014 | 181 | 0.470 |
Why?
|
| Plant Leaves | 1 | 2014 | 124 | 0.460 |
Why?
|
| Fourier Analysis | 4 | 2014 | 43 | 0.460 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 46 | 0.460 |
Why?
|
| Ferric Compounds | 1 | 2014 | 51 | 0.460 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 146 | 0.450 |
Why?
|
| Computer Simulation | 7 | 2013 | 362 | 0.450 |
Why?
|
| Crohn Disease | 2 | 2024 | 63 | 0.450 |
Why?
|
| Fluorescein | 1 | 2013 | 16 | 0.450 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2011 | 29 | 0.440 |
Why?
|
| Vibration | 3 | 2021 | 23 | 0.440 |
Why?
|
| Meat | 1 | 2013 | 43 | 0.440 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 39 | 0.440 |
Why?
|
| Middle Aged | 21 | 2020 | 10129 | 0.430 |
Why?
|
| MicroRNAs | 3 | 2023 | 426 | 0.430 |
Why?
|
| Early Detection of Cancer | 3 | 2017 | 336 | 0.430 |
Why?
|
| Laser Coagulation | 2 | 2003 | 5 | 0.420 |
Why?
|
| Models, Biological | 5 | 2012 | 677 | 0.420 |
Why?
|
| Carcinoma | 1 | 2013 | 96 | 0.420 |
Why?
|
| Diagnosis, Differential | 9 | 2019 | 217 | 0.410 |
Why?
|
| Head and Neck Neoplasms | 4 | 2018 | 78 | 0.410 |
Why?
|
| Colitis, Ulcerative | 2 | 2024 | 54 | 0.410 |
Why?
|
| Spectrophotometry, Ultraviolet | 3 | 2006 | 98 | 0.400 |
Why?
|
| Hidradenitis Suppurativa | 2 | 2021 | 3 | 0.390 |
Why?
|
| Optical Devices | 1 | 2011 | 4 | 0.390 |
Why?
|
| Terahertz Radiation | 1 | 2011 | 1 | 0.390 |
Why?
|
| Terahertz Spectroscopy | 1 | 2011 | 1 | 0.390 |
Why?
|
| Tretinoin | 2 | 2011 | 50 | 0.380 |
Why?
|
| Prostatic Hyperplasia | 1 | 2011 | 34 | 0.380 |
Why?
|
| Treatment Outcome | 9 | 2023 | 1369 | 0.370 |
Why?
|
| Spectrophotometry, Infrared | 4 | 2005 | 37 | 0.370 |
Why?
|
| Lipids | 3 | 2017 | 235 | 0.350 |
Why?
|
| Sarcoma, Kaposi | 2 | 2021 | 20 | 0.350 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 905 | 0.350 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 277 | 0.350 |
Why?
|
| Equipment Failure Analysis | 4 | 2015 | 41 | 0.350 |
Why?
|
| Nail Diseases | 2 | 2019 | 3 | 0.350 |
Why?
|
| Pilot Projects | 5 | 2023 | 661 | 0.340 |
Why?
|
| Nevus, Pigmented | 2 | 2020 | 5 | 0.340 |
Why?
|
| Nanoparticles | 1 | 2014 | 318 | 0.340 |
Why?
|
| Tensile Strength | 2 | 2011 | 25 | 0.330 |
Why?
|
| Proteins | 4 | 2013 | 369 | 0.330 |
Why?
|
| Thyroid Neoplasms | 3 | 2023 | 37 | 0.320 |
Why?
|
| ROC Curve | 3 | 2013 | 138 | 0.320 |
Why?
|
| Heat-Shock Response | 2 | 2006 | 19 | 0.320 |
Why?
|
| Aged | 15 | 2020 | 6741 | 0.320 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 2019 | 5 | 0.310 |
Why?
|
| Cerebrovascular Circulation | 2 | 2014 | 70 | 0.300 |
Why?
|
| Luminescent Measurements | 2 | 2007 | 26 | 0.300 |
Why?
|
| Mice | 6 | 2023 | 5913 | 0.300 |
Why?
|
| Adult | 18 | 2021 | 11712 | 0.300 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 583 | 0.290 |
Why?
|
| Cornea | 2 | 2004 | 58 | 0.280 |
Why?
|
| Keratosis, Actinic | 2 | 2023 | 4 | 0.270 |
Why?
|
| Fractals | 1 | 2005 | 4 | 0.270 |
Why?
|
| Connective Tissue | 1 | 2005 | 9 | 0.270 |
Why?
|
| Microscopy | 1 | 2006 | 32 | 0.270 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 9 | 0.270 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 55 | 0.270 |
Why?
|
| Biopolymers | 1 | 2005 | 18 | 0.260 |
Why?
|
| Retrospective Studies | 10 | 2020 | 2026 | 0.260 |
Why?
|
| Telemetry | 1 | 2005 | 14 | 0.260 |
Why?
|
| Circular Dichroism | 1 | 2005 | 62 | 0.260 |
Why?
|
| Colorimetry | 1 | 2005 | 40 | 0.260 |
Why?
|
| Dermatology | 2 | 2022 | 2 | 0.250 |
Why?
|
| Breast Diseases | 2 | 2002 | 6 | 0.250 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 2379 | 0.250 |
Why?
|
| Mouth Mucosa | 4 | 1998 | 34 | 0.250 |
Why?
|
| Body Water | 1 | 2004 | 26 | 0.250 |
Why?
|
| Thyroid Nodule | 2 | 2023 | 3 | 0.240 |
Why?
|
| Sclera | 1 | 2004 | 6 | 0.240 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2004 | 19 | 0.240 |
Why?
|
| Rats | 4 | 2016 | 3483 | 0.240 |
Why?
|
| Ultraviolet Rays | 2 | 2002 | 117 | 0.230 |
Why?
|
| Starvation | 1 | 2003 | 12 | 0.230 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 358 | 0.230 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 1 | 0.230 |
Why?
|
| Klinefelter Syndrome | 1 | 2023 | 3 | 0.230 |
Why?
|
| Thyroid Diseases | 1 | 2023 | 4 | 0.230 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1130 | 0.230 |
Why?
|
| Photochemotherapy | 1 | 2023 | 39 | 0.230 |
Why?
|
| Sodium Glutamate | 1 | 2003 | 3 | 0.230 |
Why?
|
| Vitreous Body | 1 | 2003 | 11 | 0.230 |
Why?
|
| Scalp | 2 | 2023 | 12 | 0.220 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 19 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2014 | 2231 | 0.220 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 15 | 0.220 |
Why?
|
| Dinitrocresols | 2 | 2013 | 2 | 0.220 |
Why?
|
| Spectrophotometry | 5 | 2011 | 70 | 0.220 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 24 | 0.220 |
Why?
|
| Area Under Curve | 2 | 2013 | 88 | 0.220 |
Why?
|
| Guinea Pigs | 2 | 2015 | 145 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 92 | 0.210 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 75 | 0.210 |
Why?
|
| Eye | 1 | 2003 | 71 | 0.210 |
Why?
|
| DNA | 3 | 2002 | 574 | 0.210 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 31 | 0.210 |
Why?
|
| Pigmentation Disorders | 2 | 2018 | 3 | 0.210 |
Why?
|
| Keratinocytes | 2 | 2018 | 66 | 0.210 |
Why?
|
| Diabetic Retinopathy | 1 | 2003 | 68 | 0.210 |
Why?
|
| Dermatitis, Perioral | 1 | 2021 | 1 | 0.210 |
Why?
|
| Time Factors | 14 | 2004 | 1742 | 0.200 |
Why?
|
| Vitis | 1 | 2022 | 31 | 0.200 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 5 | 0.200 |
Why?
|
| Glaucoma | 1 | 2003 | 85 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2021 | 33 | 0.200 |
Why?
|
| Docosahexaenoic Acids | 1 | 2021 | 18 | 0.200 |
Why?
|
| Water | 1 | 2024 | 296 | 0.200 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 213 | 0.200 |
Why?
|
| Photosystem I Protein Complex | 1 | 2021 | 3 | 0.200 |
Why?
|
| Anilides | 1 | 2021 | 28 | 0.190 |
Why?
|
| Acquired Hyperostosis Syndrome | 1 | 2021 | 2 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 182 | 0.190 |
Why?
|
| Gastrointestinal Agents | 1 | 2021 | 5 | 0.190 |
Why?
|
| Facial Neoplasms | 2 | 2017 | 6 | 0.190 |
Why?
|
| Nevus | 2 | 2020 | 5 | 0.190 |
Why?
|
| Biphenyl Compounds | 1 | 2021 | 53 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 356 | 0.190 |
Why?
|
| Molluscum Contagiosum | 1 | 2020 | 2 | 0.190 |
Why?
|
| Mouth Neoplasms | 2 | 1998 | 71 | 0.190 |
Why?
|
| Anisotropy | 2 | 2014 | 27 | 0.190 |
Why?
|
| Lichens | 1 | 2020 | 1 | 0.180 |
Why?
|
| Skin Diseases, Papulosquamous | 1 | 2020 | 1 | 0.180 |
Why?
|
| Keratosis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Pyridines | 1 | 2021 | 116 | 0.180 |
Why?
|
| Wakefulness | 1 | 2000 | 21 | 0.180 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 204 | 0.180 |
Why?
|
| Tendon Injuries | 1 | 2000 | 3 | 0.180 |
Why?
|
| Herpes Zoster | 1 | 2020 | 12 | 0.180 |
Why?
|
| Pityriasis Rubra Pilaris | 1 | 2019 | 1 | 0.180 |
Why?
|
| Child | 7 | 2023 | 3131 | 0.180 |
Why?
|
| Burns | 1 | 2000 | 7 | 0.180 |
Why?
|
| Receptors, Somatostatin | 2 | 2011 | 5 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 219 | 0.180 |
Why?
|
| Burning Mouth Syndrome | 1 | 2019 | 1 | 0.180 |
Why?
|
| Diabetes Complications | 1 | 2020 | 90 | 0.180 |
Why?
|
| Kidney | 2 | 2016 | 337 | 0.180 |
Why?
|
| Hypopigmentation | 1 | 2019 | 1 | 0.180 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 11 | 0.180 |
Why?
|
| Warts | 1 | 2019 | 5 | 0.180 |
Why?
|
| Acantholysis | 1 | 2019 | 2 | 0.180 |
Why?
|
| Blood Transfusion | 1 | 2019 | 27 | 0.180 |
Why?
|
| Scalp Dermatoses | 1 | 2019 | 1 | 0.170 |
Why?
|
| Neoplasms, Experimental | 1 | 1999 | 37 | 0.170 |
Why?
|
| Lichen Planus | 1 | 2019 | 5 | 0.170 |
Why?
|
| Mycosis Fungoides | 1 | 2019 | 2 | 0.170 |
Why?
|
| Trichophyton | 1 | 2019 | 5 | 0.170 |
Why?
|
| Hyperpigmentation | 1 | 2019 | 10 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 20 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2021 | 230 | 0.170 |
Why?
|
| Irritants | 1 | 2019 | 8 | 0.170 |
Why?
|
| Nevus, Blue | 1 | 2019 | 2 | 0.170 |
Why?
|
| Catheter Ablation | 1 | 2019 | 30 | 0.170 |
Why?
|
| Immunotherapy | 2 | 2017 | 95 | 0.170 |
Why?
|
| Forearm | 1 | 2019 | 8 | 0.170 |
Why?
|
| Bowen's Disease | 1 | 2018 | 4 | 0.170 |
Why?
|
| Granuloma | 1 | 2019 | 26 | 0.170 |
Why?
|
| Toes | 1 | 2018 | 6 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 144 | 0.170 |
Why?
|
| Arthrodermataceae | 1 | 2018 | 1 | 0.170 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 183 | 0.170 |
Why?
|
| Young Adult | 7 | 2020 | 4268 | 0.170 |
Why?
|
| Hutchinson's Melanotic Freckle | 1 | 2018 | 1 | 0.170 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2018 | 2 | 0.170 |
Why?
|
| Hemangioma, Capillary | 1 | 2018 | 2 | 0.160 |
Why?
|
| Angiokeratoma | 1 | 2018 | 2 | 0.160 |
Why?
|
| Skin Diseases, Vascular | 1 | 2018 | 4 | 0.160 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2018 | 8 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 121 | 0.160 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2018 | 10 | 0.160 |
Why?
|
| Spectrum Analysis | 4 | 2011 | 54 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 119 | 0.160 |
Why?
|
| Models, Statistical | 3 | 2011 | 180 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 282 | 0.160 |
Why?
|
| Sleep | 1 | 2000 | 152 | 0.160 |
Why?
|
| Retina | 1 | 2021 | 280 | 0.160 |
Why?
|
| Heart Failure | 1 | 2021 | 235 | 0.160 |
Why?
|
| Proteomics | 2 | 2022 | 325 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 290 | 0.160 |
Why?
|
| Tyrosine | 2 | 2021 | 118 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 68 | 0.150 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2017 | 2 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 47 | 0.150 |
Why?
|
| Melanocytes | 1 | 2017 | 6 | 0.150 |
Why?
|
| Early Diagnosis | 1 | 2017 | 64 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 20 | 0.150 |
Why?
|
| Checklist | 1 | 2017 | 13 | 0.150 |
Why?
|
| Aminoquinolines | 1 | 2017 | 14 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 360 | 0.140 |
Why?
|
| Darier Disease | 1 | 2016 | 1 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2016 | 34 | 0.140 |
Why?
|
| Tissue Distribution | 2 | 2010 | 207 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2017 | 86 | 0.140 |
Why?
|
| Bronchial Spasm | 1 | 2016 | 3 | 0.140 |
Why?
|
| Anticarcinogenic Agents | 2 | 1996 | 65 | 0.140 |
Why?
|
| Tropanes | 1 | 2016 | 6 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 618 | 0.140 |
Why?
|
| Aging | 1 | 2021 | 664 | 0.140 |
Why?
|
| Keratosis, Seborrheic | 1 | 2016 | 2 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 400 | 0.140 |
Why?
|
| Drug Carriers | 2 | 2014 | 125 | 0.140 |
Why?
|
| Statistics as Topic | 2 | 2014 | 117 | 0.130 |
Why?
|
| Nuclear Family | 1 | 2015 | 12 | 0.130 |
Why?
|
| Prevalence | 4 | 2023 | 1455 | 0.130 |
Why?
|
| Information Storage and Retrieval | 2 | 2005 | 31 | 0.130 |
Why?
|
| Cholesterol | 1 | 2016 | 205 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 617 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 195 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2019 | 753 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2019 | 400 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 65 | 0.120 |
Why?
|
| Prognosis | 4 | 2017 | 739 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2005 | 208 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 111 | 0.120 |
Why?
|
| Shear Strength | 1 | 2014 | 25 | 0.120 |
Why?
|
| Rhodopsin | 5 | 1991 | 36 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2014 | 140 | 0.120 |
Why?
|
| Flavins | 2 | 2011 | 11 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2014 | 233 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 149 | 0.120 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 23 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 113 | 0.110 |
Why?
|
| Kinetics | 14 | 2014 | 708 | 0.110 |
Why?
|
| Least-Squares Analysis | 1 | 2013 | 43 | 0.110 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2012 | 2 | 0.110 |
Why?
|
| Neuroma, Acoustic | 1 | 2012 | 2 | 0.110 |
Why?
|
| Pituitary Neoplasms | 1 | 2012 | 5 | 0.110 |
Why?
|
| Porphyrins | 2 | 2011 | 55 | 0.110 |
Why?
|
| Soybean Oil | 1 | 2012 | 3 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2012 | 19 | 0.110 |
Why?
|
| Emulsions | 1 | 2012 | 33 | 0.110 |
Why?
|
| Solutions | 1 | 2012 | 62 | 0.100 |
Why?
|
| Thermal Conductivity | 1 | 2011 | 1 | 0.100 |
Why?
|
| Quartz | 1 | 2011 | 3 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 312 | 0.100 |
Why?
|
| Diamond | 1 | 2011 | 5 | 0.100 |
Why?
|
| Aluminum Oxide | 1 | 2011 | 9 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 111 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2012 | 55 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1371 | 0.100 |
Why?
|
| Dehydration | 1 | 2011 | 21 | 0.100 |
Why?
|
| Fluorometry | 1 | 2011 | 17 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 202 | 0.100 |
Why?
|
| Mammary Glands, Animal | 1 | 2011 | 26 | 0.100 |
Why?
|
| Silicon Dioxide | 1 | 2011 | 34 | 0.100 |
Why?
|
| Cattle | 7 | 2000 | 477 | 0.100 |
Why?
|
| Phospholipids | 1 | 2012 | 70 | 0.100 |
Why?
|
| Receptors, Bombesin | 1 | 2011 | 1 | 0.100 |
Why?
|
| Lasers, Semiconductor | 1 | 2011 | 1 | 0.100 |
Why?
|
| Terahertz Imaging | 1 | 2011 | 1 | 0.100 |
Why?
|
| Lasers, Gas | 1 | 2011 | 2 | 0.100 |
Why?
|
| DNA, Neoplasm | 2 | 2002 | 92 | 0.100 |
Why?
|
| Electrons | 1 | 2011 | 68 | 0.100 |
Why?
|
| Reference Standards | 1 | 2011 | 52 | 0.100 |
Why?
|
| Lung | 2 | 1991 | 446 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 643 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 502 | 0.090 |
Why?
|
| Retinal Pigments | 4 | 1985 | 34 | 0.090 |
Why?
|
| Azo Compounds | 2 | 2000 | 20 | 0.090 |
Why?
|
| Photography | 2 | 2020 | 46 | 0.090 |
Why?
|
| Coloring Agents | 2 | 2000 | 51 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1618 | 0.090 |
Why?
|
| Dogs | 2 | 2000 | 149 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2009 | 9 | 0.090 |
Why?
|
| Keratins | 1 | 2009 | 25 | 0.090 |
Why?
|
| Italy | 2 | 2020 | 22 | 0.090 |
Why?
|
| Liver | 1 | 2012 | 479 | 0.080 |
Why?
|
| Arm | 2 | 2019 | 28 | 0.080 |
Why?
|
| Hyphae | 2 | 2019 | 36 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2023 | 893 | 0.080 |
Why?
|
| Amides | 1 | 2009 | 68 | 0.080 |
Why?
|
| Comorbidity | 2 | 2021 | 623 | 0.080 |
Why?
|
| Adolescent | 4 | 2020 | 5363 | 0.080 |
Why?
|
| Extremities | 2 | 2019 | 18 | 0.080 |
Why?
|
| Reference Values | 2 | 2005 | 212 | 0.080 |
Why?
|
| Chloroplasts | 3 | 1977 | 10 | 0.080 |
Why?
|
| Antifungal Agents | 2 | 2019 | 148 | 0.070 |
Why?
|
| Absorption | 2 | 2001 | 25 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 349 | 0.070 |
Why?
|
| Radiometry | 1 | 2005 | 8 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 1986 | 68 | 0.070 |
Why?
|
| Bombesin | 1 | 2005 | 1 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2005 | 37 | 0.070 |
Why?
|
| Virus Physiological Phenomena | 1 | 2005 | 4 | 0.070 |
Why?
|
| Miniaturization | 1 | 2005 | 6 | 0.070 |
Why?
|
| Photometry | 1 | 2005 | 5 | 0.060 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 24 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2005 | 31 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 974 | 0.060 |
Why?
|
| Mucous Membrane | 2 | 1997 | 34 | 0.060 |
Why?
|
| Polarography | 1 | 2004 | 1 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2004 | 19 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2005 | 195 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2005 | 70 | 0.060 |
Why?
|
| Polyethylene | 1 | 2004 | 3 | 0.060 |
Why?
|
| Torque | 1 | 2004 | 9 | 0.060 |
Why?
|
| Keratolytic Agents | 1 | 2023 | 3 | 0.060 |
Why?
|
| Curettage | 1 | 2023 | 3 | 0.060 |
Why?
|
| Motion | 1 | 2004 | 27 | 0.060 |
Why?
|
| Particle Size | 1 | 2004 | 215 | 0.060 |
Why?
|
| Bacteriophages | 1 | 2004 | 44 | 0.060 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2003 | 4 | 0.060 |
Why?
|
| Siderophores | 1 | 2003 | 9 | 0.060 |
Why?
|
| Photosensitizing Agents | 1 | 2023 | 49 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2023 | 17 | 0.060 |
Why?
|
| Culture Media | 1 | 2003 | 90 | 0.060 |
Why?
|
| Feces | 1 | 2023 | 111 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 11 | 0.060 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 13 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 122 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 149 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 408 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 245 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2004 | 389 | 0.050 |
Why?
|
| Galectin 1 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Carcinoma, Lobular | 1 | 2002 | 3 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 320 | 0.050 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2002 | 16 | 0.050 |
Why?
|
| Tongue Neoplasms | 1 | 2002 | 11 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2002 | 11 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 145 | 0.050 |
Why?
|
| Liver Function Tests | 1 | 2021 | 18 | 0.050 |
Why?
|
| Iron | 1 | 2003 | 225 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 143 | 0.050 |
Why?
|
| Timolol | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tooth | 1 | 1981 | 12 | 0.050 |
Why?
|
| Propranolol | 1 | 2021 | 18 | 0.050 |
Why?
|
| Potassium Compounds | 1 | 2020 | 4 | 0.050 |
Why?
|
| Hydroxides | 1 | 2020 | 7 | 0.050 |
Why?
|
| Medical Illustration | 1 | 2020 | 2 | 0.050 |
Why?
|
| Pain | 1 | 2023 | 251 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 52 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2002 | 177 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2020 | 18 | 0.050 |
Why?
|
| Alopecia | 1 | 2020 | 9 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2021 | 207 | 0.050 |
Why?
|
| Hair | 1 | 2020 | 20 | 0.050 |
Why?
|
| Syndrome | 1 | 2020 | 74 | 0.050 |
Why?
|
| Pruritus | 1 | 2020 | 3 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2020 | 61 | 0.050 |
Why?
|
| Epidermophyton | 1 | 2020 | 1 | 0.050 |
Why?
|
| Resorcinols | 1 | 2000 | 4 | 0.050 |
Why?
|
| Histological Techniques | 1 | 2000 | 14 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 1999 | 1518 | 0.050 |
Why?
|
| Dental Caries | 1 | 1981 | 57 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 58 | 0.040 |
Why?
|
| European Union | 1 | 2019 | 5 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2000 | 91 | 0.040 |
Why?
|
| Thalassemia | 1 | 2019 | 3 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 2019 | 4 | 0.040 |
Why?
|
| Dacarbazine | 1 | 2019 | 6 | 0.040 |
Why?
|
| Vinblastine | 1 | 2019 | 9 | 0.040 |
Why?
|
| Blood Component Removal | 1 | 2019 | 5 | 0.040 |
Why?
|
| Arousal | 1 | 2000 | 86 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 149 | 0.040 |
Why?
|
| Cheek | 1 | 1999 | 14 | 0.040 |
Why?
|
| Pemphigus | 1 | 2019 | 1 | 0.040 |
Why?
|
| Bleomycin | 1 | 2019 | 20 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 161 | 0.040 |
Why?
|
| Suppuration | 1 | 2019 | 3 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 1998 | 587 | 0.040 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2019 | 7 | 0.040 |
Why?
|
| Ischemia | 2 | 2000 | 46 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 46 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1999 | 29 | 0.040 |
Why?
|
| PUVA Therapy | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 16 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 1999 | 29 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 661 | 0.040 |
Why?
|
| Microglia | 1 | 2021 | 166 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 91 | 0.040 |
Why?
|
| Mohs Surgery | 1 | 2019 | 1 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 3 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 28 | 0.040 |
Why?
|
| Simian virus 40 | 1 | 1999 | 47 | 0.040 |
Why?
|
| Foot | 1 | 2019 | 10 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 133 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 238 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 93 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2019 | 84 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 60 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2019 | 61 | 0.040 |
Why?
|
| Lymphoma | 1 | 2019 | 38 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 308 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1998 | 5 | 0.040 |
Why?
|
| Eczema | 1 | 2018 | 4 | 0.040 |
Why?
|
| Diabetic Foot | 1 | 2018 | 5 | 0.040 |
Why?
|
| Carcinogens | 1 | 1999 | 124 | 0.040 |
Why?
|
| Granuloma, Pyogenic | 1 | 2018 | 2 | 0.040 |
Why?
|
| Risk Factors | 2 | 2017 | 3562 | 0.040 |
Why?
|
| Port-Wine Stain | 1 | 2018 | 2 | 0.040 |
Why?
|
| Purpura | 1 | 2018 | 3 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 33 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 224 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1039 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 339 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 148 | 0.040 |
Why?
|
| Photobiology | 1 | 1997 | 3 | 0.040 |
Why?
|
| Photophosphorylation | 2 | 1975 | 2 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 534 | 0.040 |
Why?
|
| Biological Products | 1 | 2019 | 71 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 1997 | 48 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 610 | 0.040 |
Why?
|
| Decision Trees | 1 | 2017 | 19 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 807 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1198 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 481 | 0.040 |
Why?
|
| Disease Progression | 1 | 1999 | 601 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 333 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 923 | 0.040 |
Why?
|
| Halobacterium | 1 | 1976 | 19 | 0.030 |
Why?
|
| Muscarinic Antagonists | 1 | 2016 | 12 | 0.030 |
Why?
|
| Emphysema | 1 | 2016 | 6 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 117 | 0.030 |
Why?
|
| Mammography | 1 | 1997 | 188 | 0.030 |
Why?
|
| Bacteriorhodopsins | 1 | 1976 | 36 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 311 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cell Division | 1 | 1997 | 307 | 0.030 |
Why?
|
| Bronchitis, Chronic | 1 | 2016 | 15 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 515 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 1995 | 4 | 0.030 |
Why?
|
| Mitochondria | 1 | 1999 | 487 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 290 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2018 | 325 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 336 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 628 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 1994 | 18 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2017 | 294 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 22 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 122 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1398 | 0.030 |
Why?
|
| Mass Screening | 1 | 2017 | 462 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 674 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 1549 | 0.030 |
Why?
|
| Quality of Life | 1 | 2016 | 481 | 0.030 |
Why?
|
| Pigments, Biological | 2 | 1986 | 10 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 1991 | 55 | 0.020 |
Why?
|
| Blood | 1 | 1991 | 37 | 0.020 |
Why?
|
| Plants | 4 | 1977 | 99 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 384 | 0.020 |
Why?
|
| Isomerism | 2 | 1991 | 63 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1986 | 21 | 0.020 |
Why?
|
| Luminescence | 1 | 1986 | 24 | 0.020 |
Why?
|
| Phycoerythrin | 1 | 1986 | 3 | 0.020 |
Why?
|
| Argon | 1 | 1985 | 2 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 2005 | 12 | 0.020 |
Why?
|
| Cyanobacteria | 1 | 1986 | 23 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 1985 | 41 | 0.020 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2004 | 3 | 0.020 |
Why?
|
| Viruses | 1 | 2005 | 36 | 0.020 |
Why?
|
| Energy Transfer | 4 | 1986 | 36 | 0.020 |
Why?
|
| Pseudomonadaceae | 1 | 2004 | 3 | 0.020 |
Why?
|
| Cystoviridae | 1 | 2004 | 20 | 0.010 |
Why?
|
| Telencephalon | 1 | 2000 | 14 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 58 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2000 | 107 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2000 | 343 | 0.010 |
Why?
|
| Oxygen | 1 | 2000 | 207 | 0.010 |
Why?
|
| Quantum Theory | 2 | 1975 | 78 | 0.010 |
Why?
|
| Photochemistry | 2 | 1991 | 63 | 0.010 |
Why?
|
| Cell Count | 1 | 1997 | 135 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 550 | 0.010 |
Why?
|
| Reperfusion | 1 | 1995 | 16 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1997 | 399 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1997 | 272 | 0.010 |
Why?
|
| Cell Line | 1 | 1997 | 1354 | 0.010 |
Why?
|
| Deuterium | 1 | 1991 | 12 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1986 | 96 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1983 | 167 | 0.000 |
Why?
|
| Photoreceptor Cells | 1 | 1979 | 37 | 0.000 |
Why?
|